Two global leaders, WHO for public health, and USFDA for scientific validity of food, meds, vaccines, and diagnostics appear to be taking diagonally opposite stands on repurposed medicines. That too, at a time when there are no scientifically established medicines against COVID-19 to date, Health experts in India, now say that it is time for all world leaders of science and governments to reconnect and introspect as to why all the best science and medical institutions have failed to throw up viable solutions (other than elusive vaccines) for COVID-19 and other impending pandemics, amidst different views on . Also will take legal view on drugs being administered to millions of Covid 19 patients, which get rejected by WHO or gets sanction from US FDA, what rights to patients have?

Dr Wiqar Shaikh, senior allergy and asthma specialist said, “The recent approval, of Remdesvir, by the US FDA, has the first drug to treat covid 19 comes as a complete surprise. Indeed, this is more shocking because the ‘solidarity’ trial by the WHO of which the data was released just a few days ago had thrashed both Remdesivir and HCQs in Covid 19 treatment. The WHO chief scientist Dr Soumya Swaminathan has stated that the solidarity trial, had robust results, and that Remdesivir, neither improves survival nor reduce the duration of stay in the hospital. Remdesivir also did not reduce the initiation of ventilator in those patients, not already on a ventilator support. She also observed that the US FDA appears to have not considered, the results of the WHO solidarity trial, before granting full approval to Remdesivir.